DCM
EPZM

Dupont Capital Management’s Epizyme, Inc EPZM Stock Holding History

Dupont Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,472
Closed -$352K – 1458
2020
Q3 		$352K Sell
29,472
-6,205
-17% -$83.1K 0.01% 917
2020
Q2 		$573K Buy
35,677
+22,803
+177% +$398K 0.01% 714
2020
Q1 		$200K Buy
+12,874
New +$276K ﹤0.01% 1026
2015
Q2 		– Sell
-18,186
Closed -$342K – 637
2015
Q1 		$342K Buy
18,186
+3,820
+27% +$78.9K 0.01% 540
2014
Q4 		$271K Buy
14,366
+2,130
+17% +$49.8K 0.01% 582
2014
Q3 		$332K Hold
12,236
– – 0.01% 597
2014
Q2 		$381K Hold
12,236
– – 0.01% 597
2014
Q1 		$279K Hold
12,236
– – ﹤0.01% 606
2013
Q4 		$255K Sell
12,236
-1,895
-13% -$54.9K ﹤0.01% 583
2013
Q3 		$567K Buy
+14,131
New +$479K 0.01% 545

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dupont Capital Management's EPZM Position: Q4 2020 in Review

Dupont Capital Management sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 29,472 shares — an estimated $352K sold.

Dupont Capital Management first reported a position in EPZM in Q3 2013 and held it in 10 quarters. The position peaked at $573K in Q2 2020. 137 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • Dupont Capital Management reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
  • Dupont Capital Management sold 29,472 Epizyme, Inc shares in Q4 2020, an estimated $352K.
  • Dupont Capital Management first reported a position in Epizyme, Inc in Q3 2013 and held it in 10 quarters.
  • Dupont Capital Management's Epizyme, Inc position peaked at $573K in Q2 2020.
  • 137 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.